About Guangdong Provincial People's Hospital
广东省第二人民医院是广州市最大的公立医院，位于海珠区新港路。前身为解放军一七七医院，于1947年建立，2004年更名为现名至今。 医院占地面积约5万平方米，建筑面积13.2万平方米，现有医务人员约1000名。 2020年接管民航广州医院。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Guangdong Provincial People's Hospital
During the past decade, Guangdong Provincial People's Hospital conducted 193 clinical trials. In the 10-year time frame, 193 clinical trials started and 20 clinical trials were completed, i.e. on
average, 10.4% percent of trials that started reached the finish line to date. In the past 5 years, 151 clinical trials started and 19 clinical trials were completed. i.e. 12.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Guangdong Provincial People's Hospital" #1 sponsor was "Guangdong Provincial People's Hospital" with 40 trials, followed by "Janssen Research & Development, LLC" with 8 trials
sponsored, "Boehringer Ingelheim" with 7 trials sponsored, "Pfizer" with 7 trials sponsored and "BeiGene"
with 7 trials sponsored. Other sponsors include 139 different institutions and
companies that sponsored additional 102 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Guangdong Provincial People's Hospital"
#1 collaborator was "Guangdong Provincial People's Hospital" with 18 trials as a collaborator, "Shenzhen People's Hospital" with 7 trials as a collaborator, "First Affiliated Hospital, Sun Yat-Sen University" with 6 trials as a collaborator, "Sichuan Provincial People's Hospital" with 5 trials as a collaborator and "West China Hospital" with 5 trials as a collaborator. Other collaborators include 253 different institutions and companies that were
collaborators in the rest 193 trials.
Clinical Trials Conditions at Guangdong Provincial People's Hospital
According to Clinical.Site data, the most researched conditions in "Guangdong Provincial People's Hospital" are
"Coronary Artery Disease" (9 trials), "Lung Cancer" (6 trials), "Multiple Myeloma" (5 trials), "Breast Neoplasms" (4 trials) and "Carcinoma, Non-Small-Cell Lung" (4 trials). Many other conditions were trialed in "Guangdong Provincial People's Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Guangdong Provincial People's Hospital
Most popular intervention types in "Guangdong Provincial People's Hospital" are "Drug" (145 trials), "Device" (15 trials), "Other" (15 trials), "Procedure" (14 trials) and "Biological" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (36 trials), "Cisplatin" (8 trials), "Tislelizumab" (6 trials), "Carboplatin" (4 trials) and "Daratumumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Guangdong Provincial People's Hospital
The vast majority of trials in "Guangdong Provincial People's Hospital" are
203 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at Guangdong Provincial People's Hospital
Currently, there are 131 active trials in "Guangdong Provincial People's Hospital".
7 are not yet recruiting,
88 are recruiting,
32 are Active, not recruiting,
and 4 are Enrolling by invitation.
In total, there were 40 completed trials in Guangdong Provincial People's Hospital,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Guangdong Provincial People's Hospital, 28 "Phase 1"
clinical trials were conducted, 47 "Phase 2" clinical
trials and 72 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 26 trials that are defined as “Not Applicable".